R. Amato et al., Radioimmunodetection of residual, recurrent or metastatic germ cell tumorsusing technetium-99 anti-(alpha-fetoprotein) Fab ' fragment, J CANC RES, 126(3), 2000, pp. 161-167
Purpose: The majority of patients with germ cell tumors are cured by multim
odality therapy that consists of cisplatin-based chemotherapy and/or surgic
al resection. Serum tumor markers and conventional radiographs are utilized
to stratify patients into treatment categories. Efforts tt, individualize
chemotherapy or minimize surgical interventions without compromising outcom
e are important. Immunomedics (Morris Plains, New Jersey) developed an anti
-(alpha-fetoprotein) (anti-AFP) monoclonal antibody IMMU-30 labeled with 15
-20 mCi technetium-99, and the purpose of this study is to determine the se
nsitivity and specificity of radioimmunoscintigraphy using Tc-99m anti-AFP
antibody for the diagnosis of active germ cell tumors. Methods: A group of
patients with germ cell tumors were enrolled in a non-prospective fashion a
nd 48 AFP scans using Tc-99 anti-AFP Fab' fragment were obtained. At the ti
me of the AFP scan, serum AFP was elevated in 40 measurements with a median
level of 21 ng/ml (1.6-66, 210.0 ng/ml). AFP scans were obtained at the in
itial staging, during treatment, at relapse or at long-term follow-up and c
ompared with conventional radiographs done within 4 weeks of the AFP scans.
Results: An overall diagnostic sensitivity of 89% and specificity of 58% w
ere obtained. Conclusions: AFP scanning appears useful and to be sufficient
ly sensitive to justify prospective studies comparing the procedure with co
nventional imaging.